Iradimed's Selling Steadily Plan: What It Signals Investors
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
This intro examines risk profiles for index vs target date funds, offering a clear take on volatility, diversification, and potential drawdowns.
24,893 articlesInsider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
When a major fund buys more while a stock falls, it sets up a compelling investing puzzle. This piece explains what t...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
A recent SEC filing shows Pale Fire Capital expanding its Ziff Davis position. This move offers clues about hedge fun...
Public disputes can derail a celebrity’s finances. This article uses a high-profile scenario to show you practical st...
Schwab Fundamental International Equity ETF (FNDF) packs around 900 holdings into a single fund and has posted impres...
A new AI image generator from Microsoft, MAI-Image-2, promises sharper visuals and reliable text rendering. This arti...
New to prediction markets? This friendly guide shows you how to get started with Myriad, fund your account, and start...
Poet Technologies sank today, sparking questions about its future. This analysis breaks down what happened, what it m...
Through May 2026, CWB rose about 19% year-to-date, underscoring the appeal of convertible bonds as a middle ground be...